Santagostino, E., Negrier, C., Klamroth, R., Tiede, A., Pabinger-Fasching, I., Voigt, C., . . . Morfini, M. (2012). Safety and pharmacokinetics of a novel recombinant fusion protein linking coagulation factor IX with albumin (rIX-FP) in hemophilia B patients. American Society of Hematology.
Citação norma ChicagoSantagostino, Elena, Claude Negrier, Robert Klamroth, Andreas Tiede, Ingrid Pabinger-Fasching, Christine Voigt, Iris Jacobs, and Massimo Morfini. Safety and Pharmacokinetics of a Novel Recombinant Fusion Protein Linking Coagulation Factor IX With Albumin (rIX-FP) in Hemophilia B Patients. American Society of Hematology, 2012.
Citação norma MLASantagostino, Elena, et al. Safety and Pharmacokinetics of a Novel Recombinant Fusion Protein Linking Coagulation Factor IX With Albumin (rIX-FP) in Hemophilia B Patients. American Society of Hematology, 2012.